Lioresal Stungulyf/innrennslislyf, lausn 50 míkróg/ml 冰岛 - 冰岛文 - LYFJASTOFNUN (Icelandic Medicines Agency)

lioresal stungulyf/innrennslislyf, lausn 50 míkróg/ml

novartis healthcare a/s - baclofenum inn - stungulyf/innrennslislyf, lausn - 50 míkróg/ml

Lioresal Stungulyf/innrennslislyf, lausn 0,5 mg/ml 冰岛 - 冰岛文 - LYFJASTOFNUN (Icelandic Medicines Agency)

lioresal stungulyf/innrennslislyf, lausn 0,5 mg/ml

novartis healthcare a/s - baclofenum inn - stungulyf/innrennslislyf, lausn - 0,5 mg/ml

Lioresal Stungulyf/innrennslislyf, lausn 2 mg/ml 冰岛 - 冰岛文 - LYFJASTOFNUN (Icelandic Medicines Agency)

lioresal stungulyf/innrennslislyf, lausn 2 mg/ml

novartis healthcare a/s - baclofenum inn - stungulyf/innrennslislyf, lausn - 2 mg/ml

Exagon vet. (Exagon 400) Stungulyf, lausn 400 mg/ml 冰岛 - 冰岛文 - LYFJASTOFNUN (Icelandic Medicines Agency)

exagon vet. (exagon 400) stungulyf, lausn 400 mg/ml

vetviva richter gmbh - pentobarbitalum natríum - stungulyf, lausn - 400 mg/ml

Arepanrix 欧盟 - 冰岛文 - EMA (European Medicines Agency)

arepanrix

glaxosmithkline biologicals s.a. - split influenza virus, inactivated, containing antigen*: a/california/7/2009 (h1n1)v like strain (x-179a)*propagated in eggs. - influenza, human; immunization; disease outbreaks - bólusetningar gegn inflúensu - fyrirbyggjandi inflúensu í opinberlega lýst faraldur ástandið. bólusetning gegn heimsfaraldri inflúensu ætti að nota í samræmi við opinbera leiðbeiningar.